During the last session, Jaguar Health Inc. (NASDAQ:JAGX)’s traded shares were 6.95 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $0.27, reflecting an intraday gain of 6.24% or $0.02. The 52-week high for the JAGX share is $4.20, that puts it down -1455.56 from that peak though still a striking 7.41% gain since the share price plummeted to a 52-week low of $0.25. The company’s market capitalization is $23.07M, and the average intraday trading volume over the past 10 days was 6.23 million shares, and the average trade volume was 2.46 million shares over the past three months.
Jaguar Health Inc. (JAGX) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.50. JAGX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.22.
Jaguar Health Inc. (NASDAQ:JAGX) trade information
Jaguar Health Inc. (JAGX) registered a 6.24% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 6.24% in intraday trading to $0.27 this Thursday, 08/04/22, hitting a weekly high. The stock’s 5-day price performance is -1.56%, and it has moved by -14.41% in 30 days. Based on these gigs, the overall price performance for the year is -93.36%. The short interest in Jaguar Health Inc. (NASDAQ:JAGX) is 4.78 million shares and it means that shorts have 2 day(s) to cover.
The consensus price target of analysts on Wall Street is $5.00, which implies an increase of 94.6% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5.00 and $5.00 respectively. As a result, JAGX is trading at a discount of -1751.85% off the target high and -1751.85% off the low.
Jaguar Health Inc. (JAGX) estimates and forecasts
Statistics show that Jaguar Health Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Jaguar Health Inc. (JAGX) shares have gone down -66.56% during the last six months, with a year-to-date growth rate more than the industry average at 28.81% against 11.20. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 26.70% this quarter and then jump 14.80% in the quarter after that. In the rating firms’ projections, revenue will increase 467.50% compared to the previous financial year.
Revenue for the current quarter is expected to be $3.1 million as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $4 million by the end of Sep 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $385k and $2.63 million respectively. In this case, analysts expect current quarter sales to grow by 705.20% and then jump by 52.10% in the coming quarter.
While earnings are projected to return 60.80% in 2022, the next five years will return 40.00% per annum.
Jaguar Health Inc. is due to release its next quarterly earnings on November 17. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Jaguar Health Inc. (NASDAQ:JAGX)’s Major holders
Jaguar Health Inc. insiders own 17.28% of total outstanding shares while institutional holders control 7.54%, with the float percentage being 9.12%. Renaissance Technologies, LLC is the largest shareholder of the company, while 38 institutions own stock in it. As of Mar 30, 2022, the company held over 1.52 million shares (or 1.96% of all shares), a total value of $1.08 million in shares.
The next largest institutional holding, with 1.08 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 1.38% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $0.76 million.
Also, the Mutual Funds coming in first place with the largest holdings of Jaguar Health Inc. (JAGX) shares are Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund. Data provided on Mar 30, 2022 indicates that Vanguard Extended Market Index Fund owns about 0.59 million shares. This amounts to just over 0.75 percent of the company’s overall shares, with a $0.42 million market value. The same data shows that the other fund manager holds slightly less at 0.44 million, or about 0.56% of the stock, which is worth about $0.31 million.